Work Area: Transactions

Latest content

US brokered patent market worth $166 million in 2021, new report finds

Survey of deals forms part of wider IAM Q1 2022 Special Report on patent transactions now available to subscribers

03 March 2022

The brokered patent market in 2021

Featured in Special Report 2022 Q1: Patent Dealmaking

ROI’s latest report on sales activity and reflections on 10 years of market tracking

02 March 2022

The life science royalty sales market

Featured in Special Report 2022 Q1: Patent Dealmaking

Some of the highest-value deals in intellectual property today are taking place in the burgeoning marketplace for revenue streams linked to pharmaceutical products

02 March 2022

US patent assignments in 2021

Featured in Special Report 2022 Q1: Patent Dealmaking

Six things we learned about the transactions marketplace in a year that featured notable patent deals both big and small

02 March 2022

Patent transactions in 2021

Featured in Special Report 2022 Q1: Patent Dealmaking

Staying on top of patent transactions activity is difficult, but can have significant implications for an organisation’s IP risk.

02 March 2022

The brokered patent market in 2021

Featured in Secondary Market Activity

02 March 2022

Fortress IP co-founder leaves the firm to explore new opportunities

I have nothing but good things to say about the company but it's time to move on and do something new, says Joseph Kessler

01 March 2022

Growing monetisation space in Korea is backdrop to Samsung exec's jump to NPE world

Patent transactions involving former Samsung IP head reveal context of in-house chief’s move to the licensing sector – a big uptick in local standards development and dealmaking

24 February 2022

Patent transactions in Q4 2021

Featured in Secondary Market Activity

Numbers were up from 1,587 to 1,654 between 2020 and 2021, with the biggest Q4 deal involving IBM and the Open Invention Network

23 February 2022

More is being done than ever before to monetise neglected pharma IP

Roivant’s most recent spinout shows that it is still on the hunt for deprioritised life sciences patents

22 February 2022

Unlock unlimited access to all IAM content